Richmond Pharmacology is excited to announce that Dr. Jörg Taubel, Dr.Ulrike Lorch, Nobuo Ittetsu, and Minoru Takada will be attending BioJapan 2024in Yokohama. As Asia’s premier partnering event for the global biotechnologyindustry, BioJapan offers an unparalleled opportunity to engage with leaders inlife sciences, explore new business opportunities, and discuss the latestinnovations in biotechnology. The event will feature networking sessions,exhibitions, and one-on-one partnering meetings, making it a crucial gatheringfor industry professionals.
#Red4Research is a global initiative that recognises the essential role of clinical research in improving treatment, outcomes, and the future of medicine.
Richmond Pharmacology will participate in HFA 2025 in Belgrade from 17–20 May, focusing on heart failure research, clinical trials, and scientific collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.